Literature DB >> 9489599

Nasal absorption of hydroxocobalamin in healthy elderly adults.

D Z van Asselt1, F W Merkus, F G Russel, W H Hoefnagels.   

Abstract

AIMS: To investigate the nasal absorption of hydroxocobalamin in 10 healthy elderly adults.
METHODS: In a cross-over study, blood samples were collected before administration of the drug and after 10, 20, 30, 40, 60, 120, 180 and 240 min. The plasma cobalamin concentration was determined by competitive radioisotope binding technique.
RESULTS: The maximal plasma cobalamin concentration (Cmax) after nasal administration of 750 microg hydroxocobalamin was 1900 +/- 900 pmol l(-1) (mean +/- s.d.). The maximal plasma cobalamin concentration was reached in 35 +/- 13 min (t[max]). The Cmax after nasal administration of 1500 microg hydroxocobalamin was 3500 +/- 2500 pmol l(-1) with a t(max) of 28 +/- 16 min. Both the AUC(0,240 min) and AUC(0,00) increased significantly with an increase of the dose from 750 microg to 1500 microg (P = 0.037 and P = 0.028, respectively). The nasal spray was well tolerated. No signs of irritation or local sensitivity were noted.
CONCLUSIONS: The nasal absorption of hydroxocobalamin in healthy elderly adults is rapid, high and well tolerated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489599      PMCID: PMC1873990          DOI: 10.1046/j.1365-2125.1998.00642.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Intranasal cyanocobalamin.

Authors:  V D Romeo; A Sileno; D N Wenig
Journal:  JAMA       Date:  1992-09-09       Impact factor: 56.272

Review 2.  Oral cobalamin for pernicious anemia. Medicine's best kept secret?

Authors:  F A Lederle
Journal:  JAMA       Date:  1991-01-02       Impact factor: 56.272

3.  Activity of Vitamin B12 in Addisonian Pernicious Anemia.

Authors:  R West
Journal:  Science       Date:  1948-04-16       Impact factor: 47.728

4.  The effect of molecular size on the nasal absorption of water-soluble compounds in the albino rat.

Authors:  A N Fisher; K Brown; S S Davis; G D Parr; D A Smith
Journal:  J Pharm Pharmacol       Date:  1987-05       Impact factor: 3.765

5.  Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity.

Authors:  C McMartin; L E Hutchinson; R Hyde; G E Peters
Journal:  J Pharm Sci       Date:  1987-07       Impact factor: 3.534

6.  Retention and distribution of B12 activity, and requirement for B12, following parenteral administration of hydroxocobalamin (Vibeden).

Authors:  A P Skouby
Journal:  Acta Med Scand       Date:  1966-07

7.  Epidermal growth factor and haptocorrin in nasal secretion.

Authors:  P Tønnesen; L Thim; E Nexø
Journal:  Scand J Clin Lab Invest       Date:  1990-04       Impact factor: 1.713

8.  The availability of therapeutic hydroxocobalamin to cells.

Authors:  C A Hall; J A Begley; P D Green-Colligan
Journal:  Blood       Date:  1984-02       Impact factor: 22.113

9.  High prevalence of cobalamin deficiency in elderly outpatients.

Authors:  L C Pennypacker; R H Allen; J P Kelly; L M Matthews; J Grigsby; K Kaye; J Lindenbaum; S P Stabler
Journal:  J Am Geriatr Soc       Date:  1992-12       Impact factor: 5.562

10.  Cyanocobalamin--a case for withdrawal: discussion paper.

Authors:  A G Freeman
Journal:  J R Soc Med       Date:  1992-11       Impact factor: 18.000

View more
  6 in total

Review 1.  Vitamin B12 (cobalamin) deficiency in elderly patients.

Authors:  Emmanuel Andrès; Noureddine Henoun Loukili; Esther Noel; Georges Kaltenbach; Maher Ben Abdelgheni; Anne Elisabeth Perrin; Marie Noblet-Dick; Frédéric Maloisel; Jean-Louis Schlienger; Jean-Frédéric Blicklé
Journal:  CMAJ       Date:  2004-08-03       Impact factor: 8.262

Review 2.  Update on oral cyanocobalamin (vitamin B12) treatment in elderly patients.

Authors:  Emmanuel Andrès; Thomas Vogel; Laure Federici; Jacques Zimmer; Georges Kaltenbach
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  Systematic Review and Pragmatic Clinical Approach to Oral and Nasal Vitamin B12 (Cobalamin) Treatment in Patients with Vitamin B12 Deficiency Related to Gastrointestinal Disorders.

Authors:  Emmanuel Andrès; Abrar-Ahmad Zulfiqar; Khalid Serraj; Thomas Vogel; Georges Kaltenbach
Journal:  J Clin Med       Date:  2018-09-26       Impact factor: 4.241

4.  Cobalamin deficiency in elderly patients: a personal view.

Authors:  Emmanuel Andrès; Thomas Vogel; Laure Federici; Jacques Zimmer; Ecaterina Ciobanu; Georges Kaltenbach
Journal:  Curr Gerontol Geriatr Res       Date:  2008-05-26

5.  Effect of administration route on the pharmacokinetics of cobalamin in elderly patients: a randomized controlled trial.

Authors:  Monique P H Tillemans; Eline M V J Donders; Sjoerd L Verweij; Ruud T M Van der Hoeven; Kees J Kalisvaart
Journal:  Curr Ther Res Clin Exp       Date:  2014-03-20

Review 6.  Current Nanocarrier Strategies Improve Vitamin B12 Pharmacokinetics, Ameliorate Patients' Lives, and Reduce Costs.

Authors:  Marco Fidaleo; Stefano Tacconi; Carolina Sbarigia; Daniele Passeri; Marco Rossi; Ada Maria Tata; Luciana Dini
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.